{"transactions":[{"id":3786450,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":162884,"kind":"person","name":"Stauffer Joseph William","position":1,"cik":"0001466459","reported_name":"Stauffer Joseph William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-19T16:34:47.000Z","date":"2018-10-17","kind":"sale","acquired":false,"shares":970,"price":20.69,"value":20069.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 7, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 - $20.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-18-055688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466459/000120919118055688/doc4.xml","form_type":"4"}},{"id":3786449,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":162884,"kind":"person","name":"Stauffer Joseph William","position":1,"cik":"0001466459","reported_name":"Stauffer Joseph William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-19T16:34:47.000Z","date":"2018-10-17","kind":"sale","acquired":false,"shares":10472,"price":20.08,"value":210277.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 7, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.60 - $20.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2970,"source":{"system":"sec-edgar","filing":"0001209191-18-055688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466459/000120919118055688/doc4.xml","form_type":"4"}},{"id":3998266,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":162884,"kind":"person","name":"Stauffer Joseph William","position":1,"cik":"0001466459","reported_name":"Stauffer Joseph William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-13T18:37:01.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":57750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 9, 2018, in each case subject to the Reporting Person's Continuous service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date."}],"balance_after":57750,"derivative":{"exercise_price":14.39,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":57750},"source":{"system":"sec-edgar","filing":"0001209191-18-019405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466459/000120919118019405/doc4.xml","form_type":"4"}},{"id":4390786,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":162884,"kind":"person","name":"Stauffer Joseph William","position":1,"cik":"0001466459","reported_name":"Stauffer Joseph William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-10T17:18:51.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 8, 2017, in each case subject to the Reporting Person's Continuous service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date."}],"balance_after":75000,"derivative":{"exercise_price":17.41,"expiration_date":"2027-03-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-17-019913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466459/000120919117019913/doc4.xml","form_type":"4"}}]}